Fulton Breakefield Broenniman’s Applied Materials AMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$626K Sell
1,831
-142
-7% -$47.8K 0.04% 110
2025
Q4
$507K Buy
1,973
+13
+0.7% +$3.12K 0.03% 126
2025
Q3
$401K Buy
1,960
+139
+8% +$25.2K 0.03% 142
2025
Q2
$333K Buy
1,821
+216
+13% +$34.2K 0.02% 149
2025
Q1
$233K Sell
1,605
-88
-5% -$14.8K 0.02% 164
2024
Q4
$275K Sell
1,693
-197
-10% -$35.7K 0.02% 154
2024
Q3
$382K Hold
1,890
0.03% 128
2024
Q2
$446K Buy
1,890
+4
+0.2% +$859 0.03% 122
2024
Q1
$389K Hold
1,886
0.03% 128
2023
Q4
$306K Hold
1,886
0.02% 138
2023
Q3
$261K Sell
1,886
-57
-3% -$8.17K 0.02% 149
2023
Q2
$281K Buy
1,943
+57
+3% +$7.13K 0.02% 150
2023
Q1
$232K Sell
1,886
-767
-29% -$88.1K 0.02% 159
2022
Q4
$258K Buy
2,653
+2
+0.1% +$192 0.02% 155
2022
Q3
$217K Buy
2,651
+2
+0.1% +$193 0.02% 154
2022
Q2
$241K Buy
+2,649
New +$291K 0.02% 153
2022
Q1
Sell
-1,645
Closed -$259K 165
2021
Q4
$259K Buy
+1,645
New +$238K 0.02% 174

Other funds holding AMAT

Fulton Breakefield Broenniman's AMAT Position: Q1 2026 in Review

Fulton Breakefield Broenniman reduced its Applied Materials (AMAT) stake by 7.2% in Q1 2026, selling an estimated $47.8K and leaving 1,831 shares worth $626K. The position accounts for 0.04% of the portfolio, ranked #110.

Fulton Breakefield Broenniman first reported a position in AMAT in Q4 2021 and has held it in 17 quarters since. 2,928 funds tracked by Wall St. Rank hold AMAT as of Q1 2026.

  • Fulton Breakefield Broenniman held 1,831 shares of Applied Materials worth $626K as of Q1 2026.
  • Fulton Breakefield Broenniman sold 142 Applied Materials shares in Q1 2026, an estimated $47.8K.
  • Applied Materials made up 0.04% of Fulton Breakefield Broenniman's portfolio in Q1 2026, its #110 holding.
  • Fulton Breakefield Broenniman first reported a position in Applied Materials in Q4 2021 and has held it in 17 quarters since.
  • 2,928 funds tracked by Wall St. Rank held Applied Materials as of Q1 2026.

Based on Fulton Breakefield Broenniman's 13F filing for Q1 2026, filed 27 Apr 2026.